1 year return (CAGR)
-13.73%
Galectin Therapeutics Inc Exchange (NASDAQ, USD)
GALT
3.90
+0.07 (+1.80%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
27.51%
5 year return (CAGR)
0.72%
10 year return (CAGR)
8.95%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
399.36M
Price/Sales
-
Ent value
537.77M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-0.86%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
3.23%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.91 |
| Daily high | 4.02 |
| Daily low | 3.85 |
| Daily Volume | 258K |
| All-time high | 36.84 |
| 1y analyst estimate | 11.00 |
| Beta | 0.39 |
| EPS (TTM) | -0.42 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| GALT | S&P500 | |
| Current price drop from All-time high | -89.41% | -0.84% |
| Highest price drop | -99.02% | -56.47% |
| Date of highest drop | 17 Nov 2008 | 9 Mar 2009 |
| Avg drop from high | -82.31% | -10.68% |
| Avg time to new high | 354 days | 12 days |
| Max time to new high | 5790 days | 1805 days |
News
